Insider Shareholders with Direct Ownership of Foghorn Therapeutics Inc. (FHTX)
This section provides a comprehensive overview of the insiders with direct ownership of Foghorn Therapeutics Inc. (FHTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Foghorn Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,231,081 | 0 | 1,231,081 $6.27 Million | 1 |
Oct 27, 2020
Added 10.86%
|
|
|
Carl Decicco
Chief Scientific Officer |
109,810 | 0 | 362,707 $1.85 Million | 2 |
Dec 09, 2021
Added 22.34%
|
| 0 | 333,333 | 295,000 $1.5 Million | 1 |
Dec 14, 2021
Reduced 53.05%
|
|
|
Adrian Gottschalk
Chief Executive Officer |
67,371 | 190,850 | 186,479 $949,178 | 6 |
Sep 16, 2022
Added 17.66%
|
|
Steven F. Bellon
Chief Scientific Officer |
6,250 | 20,000 | 101,957 $518,961 | 3 |
Sep 09, 2024
Reduced 16.4%
|
|
Fanny Cavalie
Chief Strategy/Bus Ops Officer |
0 | 11,000 | 75,992 $386,799 | 1 |
Mar 11, 2024
Reduced 12.64%
|
|
Allan Reine
Chief Financial Officer |
26,892 | 0 | 53,784 $273,760 | 1 |
Aug 09, 2021
Added 33.33%
|
| 82,000 | 47,939 | 34,061 $173,370 | 2 |
Sep 13, 2022
Reduced 58.46%
|
|
|
Carlos Costa
Chief People Officer |
58,859 | 58,859 | 0 $0 | 10 |
Sep 23, 2024
Reduced 100.0%
|
|
Samuel Agresta
Chief Medical Officer |
311,297 | 311,297 | 0 $0 | 2 |
Aug 16, 2023
Reduced 100.0%
|